UBS AM Portfolio holdings
UBS Asset Management (UBS AM), a division of UBS Group AG with origins tied to the bank’s founding in 1862, is headquartered in Zurich, Switzerland, and manages hundreds of billions in assets for institutional, intermediary, and wealth management clients globally. Specializing in a broad range of investment strategies—including equities, fixed income, multi-asset, alternatives, and sustainable investing—UBS AM leverages the firm’s extensive research capabilities and global network to deliver tailored solutions. Known for its focus on risk management and innovation, it offers products like ETFs, index funds, and private market investments, catering to diverse needs from pension funds to high-net-worth individuals. As part of UBS’s broader ecosystem, UBS AM combines Swiss precision with a commitment to ESG principles, solidifying its position as a leader in the asset management industry.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Broadcom
AVGO
|
+$494M |
| 2 |
Johnson & Johnson
JNJ
|
+$466M |
| 3 |
Procter & Gamble
PG
|
+$299M |
| 4 |
Amazon
AMZN
|
+$285M |
| 5 |
Advanced Micro Devices
AMD
|
+$256M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
VMW
VMware, Inc
VMW
|
+$510M |
| 2 |
ATVI
Activision Blizzard
ATVI
|
+$430M |
| 3 |
Microsoft
MSFT
|
+$315M |
| 4 |
Intel
INTC
|
+$227M |
| 5 |
SPLK
Splunk Inc
SPLK
|
+$169M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 31.22% |
| 2 | Healthcare | 12.65% |
| 3 | Consumer Discretionary | 11.43% |
| 4 | Financials | 11.23% |
| 5 | Communication Services | 7.95% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
801
Murphy USA
MUSA
$9.61B
| $15.9M | 0.01% |
44,453
+3
| +0% | +$1.09K |
|
802
Surgery Partners
SGRY
$2.03B
| $15.8M | 0.01% |
495,442
+98,078
| +25% | +$2.85M |
|
803
WEX
WEX
$6.31B
| $15.7M | 0.01% |
80,779
+2,822
| +4% | +$512K |
|
804
Guidewire Software
GWRE
$14.2B
| $15.7M | 0.01% |
143,681
+11,623
| +9% | +$1.11M |
|
805
SITE Centers
SITC
$165M
| $15.6M | 0.01% |
1,466,408
+79,857
| +6% | +$796K |
|
806
Sarepta Therapeutics
SRPT
$1.77B
| $15.5M | 0.01% |
161,012
-170
| -0.1% | -$16.3K |
|
807
Penumbra
PEN
$12.8B
| $15.5M | 0.01% |
61,673
+2,143
| +4% | +$474K |
|
808
XPO
XPO
$23.7B
| $15.5M | 0.01% |
176,537
-4,454
| -2% | -$363K |
|
809
PVH
PVH
$4.04B
| $15.4M | 0.01% |
126,421
-755
| -0.6% | -$67.6K |
|
810
Urban Edge Properties
UE
$2.73B
| $15.4M | 0.01% |
841,784
+268,549
| +47% | +$4.42M |
|
811
Landstar System
LSTR
$6.21B
| $15.4M | 0.01% |
79,334
-704
| -0.9% | -$125K |
|
|
ITCI
812
DELISTED
Intra-Cellular Therapies Inc.
ITCI
| $15.3M | 0.01% |
214,281
+4,346
| +2% | +$250K |
|
813
Wheaton Precious Metals
WPM
$60.9B
| $15.3M | 0.01% |
309,431
| – | – |
|
814
Primerica
PRI
$9.89B
| $15.2M | 0.01% |
74,085
+1,387
| +2% | +$283K |
|
815
New York Times
NYT
$10.2B
| $15.2M | 0.01% |
310,681
+20,086
| +7% | +$886K |
|
816
Denali Therapeutics
DNLI
$3.97B
| $15.2M | 0.01% |
708,339
+65,039
| +10% | +$1.29M |
|
|
SGI
817
Somnigroup International
SGI
$13.7B
| $15.1M | 0.01% |
296,367
-26,237
| -8% | -$1.11M |
|
818
iShares MSCI Taiwan ETF
EWT
$11.1B
| $15.1M | 0.01% |
328,009
-16,000
| -5% | -$742K |
|
|
MPT
819
Medical Properties Trust
MPT
$2.81B
| $15M | 0.01% |
3,049,457
-31,202
| -1% | -$153K |
|
820
Sabra Healthcare REIT
SBRA
$5.37B
| $14.9M | 0.01% |
1,046,342
-34,824
| -3% | -$495K |
|
821
AeroVironment
AVAV
$9.45B
| $14.9M | 0.01% |
118,417
+36,354
| +44% | +$4.45M |
|
|
BERY
822
DELISTED
Berry Global Group, Inc.
BERY
| $14.9M | 0.01% |
240,990
-26,901
| -10% | -$1.52M |
|
823
Royal Gold
RGLD
$19.5B
| $14.9M | 0.01% |
123,176
-34,947
| -22% | -$3.95M |
|
824
Exelixis
EXEL
$13.4B
| $14.9M | 0.01% |
620,525
+5,608
| +0.9% | +$122K |
|
825
AGCO
AGCO
$7.2B
| $14.9M | 0.01% |
122,592
-6,464
| -5% | -$756K |
|
Similar funds
UBS AM's Q4 2023 Portfolio in Review
As of Q4 2023, UBS AM held 2,644 positions worth $254B, up 14% from $223B the previous quarter. Its ten largest holdings account for 26% of the portfolio.
UBS AM's Q4 2023 filing shows 62 new, 1,338 increased, 675 reduced and 106 closed positions. Its largest new stake was Veralto: 1,187,566 shares worth $97.7M. The largest sale was VMware, Inc, an estimated $510M.
By sector, the portfolio is most concentrated in Technology at 31% of assets, up from 30% a quarter earlier, followed by Healthcare and Consumer Discretionary.
- UBS AM's largest Q4 2023 buy was Veralto: 1,187,566 shares worth $97.7M.
- UBS AM added most to Broadcom in Q4 2023, an estimated $494M increase.
- UBS AM's biggest Q4 2023 reduction was Microsoft, cutting an estimated $315M.
- UBS AM fully exited VMware, Inc in Q4 2023, selling an estimated $510M.
- UBS AM's ten largest holdings make up 26% of its $254B portfolio in Q4 2023.
- UBS AM opened 62 new positions and closed 106 in Q4 2023.
- UBS AM's portfolio value rose 14% quarter-over-quarter to $254B.
Based on UBS AM's 13F filing for Q4 2023, filed 14 Feb 2024.